Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

New Inverness respiratory test range offers rapid diagnosis of community acquired pneumonia

Inverness Medical Innovations : 09 January, 2008  (New Product)
Inverness Medical has responded to the need to rapidly and accurately diagnose Community Acquired Pneumonia (CAP) by introducing BinaxNOW S pneumoniae and Legionella, part of the BinaxNOW range of rapid respiratory tests.
Across Europe and the USA, CAP affects 100 per 100,000 adults a year with a mortality rate of 10 to 20 percent (Ref 1). However, research indicates that where antibiotic therapy has been received within four hours of admission there has been a 15 percent reduction in mortality (Ref 2).

The simple, swab based BinaxNOW S pneumoniae and Legionella immunochromatographic assays provide clear reliable results in as little as 15 minutes from urine samples.

Through BinaxNOW’s ability to test and provide patients with their results in one visit, healthcare professionals can ensure the most appropriate treatment is administered without delay and that hospitalisation and potentially life threatening complications are avoided. With clinical guidelines advising against the routine use of antibiotics for respiratory tract infections (Ref 3).

BinaxNOW helps reduce inappropriate antibiotic prescribing and in turn prevent the risk of antibiotic resistance occurring in strains of respiratory infections. Additionally, the BinaxNOW S pneumoniae rapid test can also be used for the swift diagnosis of pneumococcal meningitis from cerebro spinal fluid (CSF).

The BinaxNOW range of rapid tests for respiratory infections covers Influenza A and B, Legionella, RSV, Strep A and S pneumoniae. With an easy to use patented book-shaped test device, Inverness Medical continues to enable early and accurate diagnosis of disease with its BinaxNOW rapid tests.

Ref 1 - World Health Organisation

Ref 2 - Houck 2004 (2004 ArchInternMed Mar 22; 164(6): 637-44)

Ref 3 - National Prescribing Centre. The management of common infections in primary care. MeReC Bulletin 2006; 17: No 3.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo